Key Takeaways
- Nexus Venture Partners books 8.8X return on its early Turtlemint investment, validating the insurtech thesis in India
- Peak XV Partners sells ₹66.2 Cr worth of shares at 7.2X returns while retaining a ₹736 Cr stake
- Turtlemint valued at ₹4,513 Cr ($475 Mn), but the company still posted ₹187 Cr loss in 9M FY26
Turtlemint's shares list on Indian exchanges Monday, June 29, after an IPO that was 1.2X oversubscribed. The real story is the payout table for early backers: Nexus Venture Partners walks away with an 8.8X return, Peak XV Partners pockets ₹66.2 Cr, and UK-based Hummingbird Ventures tops them all with a 13X gain.
The insurtech company priced its shares at ₹152, the upper end of its ₹144-₹152 band, giving it a market cap of ₹4,513 Cr (roughly $475 Mn). The public issue combined a fresh equity raise of ₹660.7 Cr with an offer for sale (OFS) of up to 1.46 Cr shares from promoters and existing investors.
Who made money and how much?
Peak XV Partners, one of Turtlemint's largest shareholders, sold 43.56 lakh shares through the OFS at ₹152 apiece. That netted ₹66.2 Cr and a 7.2X return on the original investment. Peak XV still holds 4.84 Cr shares worth ₹736.5 Cr at the issue price.
Nexus Venture Partners, which backed Turtlemint in its early institutional rounds, offloaded 27.47 lakh shares worth ₹41.75 Cr. The 8.8X return reflects patient capital in a category that took nearly a decade to reach public markets. Nexus retains 5.22 Cr shares worth ₹793.4 Cr, making it the largest holding among selling shareholders.
Hummingbird Ventures clocked the best multiple. The UK firm's 13X return came from selling just 1.89 lakh shares for ₹2.9 Cr. It still holds 21.12 lakh shares worth ₹32.1 Cr.
Blume Ventures participated through two funds. Blume Ventures Fund 1X recorded a modest 1.6X, while Blume Ventures (Opportunities) Fund IIA posted 3.8X. Combined proceeds: ₹16.5 Cr. Blume continues to hold 1.08 Cr shares worth ₹165 Cr across both vehicles.
GGV Capital sold 11.91 lakh shares for ₹18.11 Cr at a 1.9X gain. Dream Incubator, the Japan-based investor, exited 2.03 lakh shares for ₹3.08 Cr, booking 1.8X.
Co-founders cash out ₹65 Cr
Anand Rohidas Prabhudesai and Dhirendra Nalin Mahyavanshi, who founded Turtlemint in 2015, sold partial stakes through the IPO. Prabhudesai offloaded 21.12 lakh shares for ₹32.1 Cr and retains 1.9 Cr shares worth ₹289 Cr. Mahyavanshi sold 22.11 lakh shares worth ₹33.6 Cr and holds 1.98 Cr shares valued at ₹302.4 Cr.
Neither has exited meaningfully. Their combined post-IPO stake is worth nearly ₹600 Cr, which means their economic interest stays aligned with public shareholders for now.
What does Turtlemint actually do?
Turtlemint operates an insurance distribution platform. It connects consumers with insurers through a network of financial advisors for car, bike, health, and term life insurance. The model sits between pure-play aggregators like Policybazaar and traditional agent networks.
The company plans to deploy IPO proceeds toward technology infrastructure, product development, marketing, working capital, and acquisitions. Ahead of listing, Turtlemint raised ₹397.2 Cr from anchor investors by allotting 2.61 Cr shares. Seven domestic mutual funds participated via 12 schemes. Societe Generale, 360 One, Amansa Holdings, BNP Paribas, and Citi Group also came in.
Financials: growth is real, profit is not
Revenue jumped 80% year-on-year to ₹741.1 Cr in the first nine months of FY26, up from ₹411.1 Cr in the same period a year earlier. But losses also widened: ₹187.3 Cr in 9M FY26 versus ₹154.7 Cr in 9M FY25, a 20% increase.
The tension is familiar. Growth burns cash. Marketing spend and advisor network expansion eat into margins. The question is whether unit economics improve as scale kicks in. Policybazaar, the closest listed peer, took years after its IPO to post consistent operating profits.
Why these returns matter beyond Turtlemint
India's insurtech sector has struggled to prove the VC thesis. Policybazaar listed in 2021 and spent years underwater. Digit Insurance, despite strong backing, faced a bumpy path. Turtlemint's IPO, even at modest oversubscription, signals that public markets are willing to price insurance distribution models.
The 8.8X and 13X returns for Nexus and Hummingbird respectively show that patient capital in Indian insurtech can generate strong exits. For LPs watching fund performance, this is a data point. For founders building in the space, it's proof of a path to liquidity.
Logicity's Take
Turtlemint's IPO is less about the company and more about what it validates: Indian insurtech can deliver venture-scale returns. An 8.8X exit for Nexus, after nearly a decade, is solid DPI for a category that looked dead two years ago. But fintech teams eyeing this space should note the competitive pressure. Policybazaar (market cap ~₹15,000 Cr) dominates aggregation. Acko and Digit own direct-to-consumer. Turtlemint's agent-led model occupies an interesting middle ground, but margins stay thin as long as acquisition costs run high. Watch how listing-day trading goes. If the stock holds above issue price, expect more insurtech IPO filings by Q3.
Frequently Asked Questions
When is Turtlemint listing on the stock exchange?
Turtlemint shares are scheduled to list on BSE and NSE on Monday, June 29, 2025.
What return did Nexus Venture Partners make on Turtlemint?
Nexus Venture Partners booked an 8.8X return on its initial investment by selling 27.47 lakh shares worth ₹41.75 Cr through the IPO.
What is Turtlemint's IPO valuation?
At the upper price band of ₹152 per share, Turtlemint is valued at ₹4,513 Cr, approximately $475 Mn.
Is Turtlemint profitable?
No. Turtlemint reported a net loss of ₹187.3 Cr in the first nine months of FY26, up 20% from the prior year period.
How much did Turtlemint's founders make from the IPO?
Co-founders Anand Prabhudesai and Dhirendra Mahyavanshi sold shares worth a combined ₹65 Cr through the public issue.
Need Help Implementing This?
Evaluating insurtech investments or building distribution platforms? Logicity's fintech research team tracks Indian insurance startups, public market comps, and regulatory shifts. Reach out for custom analysis or portfolio reviews.
Source: Inc42 Media / Anjali Jain
Huma Shazia
Senior AI & Tech Writer
Produced with AI assistance and reviewed by the Logicity editorial team. Learn more in our Editorial Policy.
